Document Detail

The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior.
MedLine Citation:
PMID:  20713079     Owner:  NLM     Status:  MEDLINE    
Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors, and may be useful clinically as appetite suppressants. However, there may also be undesirable side effects (e.g., nausea, malaise, anxiety, and depression) that are produced by the current generation of CB1 inverse agonists such as rimonabant and taranabant. For that reason, it is important to continue research on novel cannabinoid antagonists. The present studies examined the effects of the novel compound AM6545, which is a neutral antagonist of CB1 receptors that is thought to have relatively poor penetrability into the central nervous system. Intraperitoneal administration of AM6545 significantly reduced food-reinforced operant responding at doses of 4.0, 8.0 and 16.0 mg/kg. AM6545 also produced a strong suppression of the intake of high-carbohydrate and high-fat diets in the same dose range, but only produced a mild suppression of lab chow intake at the highest dose (16.0 mg/kg). Although AM6545 did not affect food handling, it did reduce time spent feeding and feeding rate. Taken together, these results suggest that AM6545 is a compound that warrants further study as a potential appetite suppressant drug.
P A Randall; V K Vemuri; K N Segovia; E Ferreris Torres; S Hosmer; E J Nunes; J L Santerre; A Makriyannis; J D Salamone
Related Documents :
19336249 - Convergent, not serial, striatal and pallidal circuits regulate opioid-induced food int...
2874769 - Serotoninergic mechanisms in human feeding: the pharmacological evidence.
7291249 - Opioid modulation of ingestive behavior.
4048359 - Naloxone reduces food intake in humans.
23585029 - Maximising umami taste in meat using natural ingredients: effects on chemistry, sensory...
20116849 - Central litorin injection is associated with primary anorexigenic effects that coincide...
23458629 - Intrinsic and extrinsic influences on children's acceptance of new foods.
23324529 - Clostridium difficile in foods and animals: history and measures to reduce exposure.
22132819 - Influence of nutritional knowledge on the use and interpretation of spanish nutritional...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural     Date:  2010-08-14
Journal Detail:
Title:  Pharmacology, biochemistry, and behavior     Volume:  97     ISSN:  1873-5177     ISO Abbreviation:  Pharmacol. Biochem. Behav.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-11     Completed Date:  2011-09-15     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  0367050     Medline TA:  Pharmacol Biochem Behav     Country:  United States    
Other Details:
Languages:  eng     Pagination:  179-84     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Appetite Depressants / pharmacology
Dietary Carbohydrates / administration & dosage
Dietary Fats / administration & dosage
Eating / drug effects*,  physiology,  psychology
Feeding Behavior / drug effects*,  physiology,  psychology
Morpholines / pharmacology*
Pyrazoles / pharmacology*
Rats, Sprague-Dawley
Receptor, Cannabinoid, CB1 / antagonists & inhibitors*,  physiology
Reinforcement (Psychology)*
Grant Support
P01 DA009158/DA/NIDA NIH HHS; P01 DA009158-14/DA/NIDA NIH HHS
Reg. No./Substance:
0/AM6545; 0/Appetite Depressants; 0/Dietary Carbohydrates; 0/Dietary Fats; 0/Morpholines; 0/Pyrazoles; 0/Receptor, Cannabinoid, CB1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of vitamin D3 upregulated protein 1 in thioacetamide-induced mouse hepatotoxicity.
Next Document:  Audit on prevention and early diagnosis of chronic kidney disease in patients admitted to medical wa...